HK1206970A1 - Antigenic compositions and methods - Google Patents
Antigenic compositions and methodsInfo
- Publication number
- HK1206970A1 HK1206970A1 HK15107492.1A HK15107492A HK1206970A1 HK 1206970 A1 HK1206970 A1 HK 1206970A1 HK 15107492 A HK15107492 A HK 15107492A HK 1206970 A1 HK1206970 A1 HK 1206970A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- antigenic compositions
- antigenic
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261618021P | 2012-03-30 | 2012-03-30 | |
US201261647105P | 2012-05-15 | 2012-05-15 | |
PCT/US2013/033071 WO2013148427A1 (en) | 2012-03-30 | 2013-03-20 | Antigenic compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1206970A1 true HK1206970A1 (en) | 2016-01-22 |
Family
ID=48040469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15107492.1A HK1206970A1 (en) | 2012-03-30 | 2015-08-04 | Antigenic compositions and methods |
Country Status (13)
Country | Link |
---|---|
US (3) | US8883717B2 (es) |
EP (1) | EP2830652B1 (es) |
JP (1) | JP6228967B2 (es) |
CN (2) | CN106110320A (es) |
AU (1) | AU2013240106B2 (es) |
BR (1) | BR112014024375B1 (es) |
CA (1) | CA2868455C (es) |
DK (1) | DK2830652T3 (es) |
ES (1) | ES2612357T3 (es) |
HK (1) | HK1206970A1 (es) |
IL (1) | IL234695B (es) |
MX (1) | MX350707B (es) |
WO (1) | WO2013148427A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011276251B2 (en) * | 2010-07-07 | 2015-02-05 | Artifical Cell Technologies, Inc. | Respiratory syncytial virus antigenic compositions and methods |
US8883717B2 (en) | 2012-03-30 | 2014-11-11 | Artificial Cell Technologies, Inc. | Antigenic compositions and methods |
US9433671B2 (en) | 2012-03-30 | 2016-09-06 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
MX2016014863A (es) | 2014-05-27 | 2017-06-21 | Artificial Cell Tech Inc | Construccion capa a capa automatizada de nucleos recubiertos con multiples capas mediante fft. |
US20160023404A1 (en) * | 2014-07-25 | 2016-01-28 | Stephen Raymond Anderson | Three-dimensional manufacturing, fabricating, forming, and/or repairing apparatus and method |
US9968665B2 (en) | 2015-09-16 | 2018-05-15 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
CN112390660B (zh) * | 2020-10-29 | 2022-08-09 | 成都聚力混凝土有限公司 | 一种护坡绿化专用的植被混凝土及其制备方法 |
US20230414526A1 (en) * | 2022-03-29 | 2023-12-28 | Artificial Cell Technologies, Inc. | Respiratory syncytial virus antigenic compositions and methods |
US20240122845A1 (en) * | 2022-09-20 | 2024-04-18 | Artificial Cell Technologies, Inc. | Administration regimens for microneedle patch devices for delivery of immunogenic compositions |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723130A (en) | 1993-05-25 | 1998-03-03 | Hancock; Gerald E. | Adjuvants for vaccines against respiratory syncytial virus |
AU690567B2 (en) * | 1993-07-12 | 1998-04-30 | Avant Immunotherapeutics, Inc. | Hydrogel microencapsulated vaccines |
US7101575B2 (en) | 1998-03-19 | 2006-09-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
DE10001172A1 (de) | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templatieren von Feststoffpartikeln mit Polymermultischichten |
CN1688605B (zh) * | 2002-08-12 | 2011-01-12 | 昆士兰医学研究所理事会 | 包含辅助t细胞和细胞毒性t淋巴细胞(ctl)表位的新免疫原性脂肽 |
EP1617871A4 (en) | 2003-04-10 | 2010-10-06 | 3M Innovative Properties Co | DISTRIBUTION OF IMMUNE-RESPONSE-MODIFYING COMPOUNDS USING PARTICULATE CARRIER MATERIALS CONTAINING METAL |
US7615530B2 (en) | 2003-08-29 | 2009-11-10 | Artificial Cell Technologies, Inc. | Immunogenic compositions and methods of use |
US7348399B2 (en) | 2003-08-29 | 2008-03-25 | Louisiana Tech University Foundation, Inc. | Nanofabricated polypeptide multilayer films, coatings, and microcapsules |
DE102004013637A1 (de) | 2004-03-19 | 2005-10-13 | Capsulution Nanoscience Ag | Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln |
US7282194B2 (en) * | 2004-10-05 | 2007-10-16 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
EP1850832B1 (en) * | 2005-02-07 | 2014-12-31 | Lipotek PTY Ltd | Adjuvanting material |
DE102005044400A1 (de) | 2005-09-16 | 2007-03-22 | Capsulution Nanoscience Ag | Verfahren zur Verkapselung und kontrollierten Freisetzung von schwer wasserlöslichen (hydrophoben) flüssigen und festen Wirkstoffen |
ES2400665T3 (es) | 2005-10-25 | 2013-04-11 | Artificial Cell Technologies, Inc. | Composiciones inmunógenas y procedimientos de uso |
EP1988896A4 (en) | 2006-02-22 | 2011-07-27 | 3M Innovative Properties Co | CONJUGATES TO MODIFY IMMUNE REACTIONS |
US20080149123A1 (en) | 2006-12-22 | 2008-06-26 | Mckay William D | Particulate material dispensing hairbrush with combination bristles |
US7723294B2 (en) | 2007-04-02 | 2010-05-25 | Artificial Cell Technologies, Inc. | Polypeptide films and methods |
EP2002847A1 (en) | 2007-06-12 | 2008-12-17 | Capsulution Nanoscience AG | Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device |
WO2009082440A2 (en) | 2007-12-18 | 2009-07-02 | Vaxinnate Corporation | Compositions of toll-like receptor agonists and malaria antigens and methods of use |
US7846824B2 (en) | 2008-03-18 | 2010-12-07 | Applied Materials, Inc. | Methods for forming a titanium nitride layer |
WO2010115229A1 (en) * | 2009-04-09 | 2010-10-14 | The University Of Melbourne | Immunogenic composition and uses thereof |
AU2011276251B2 (en) | 2010-07-07 | 2015-02-05 | Artifical Cell Technologies, Inc. | Respiratory syncytial virus antigenic compositions and methods |
JP5991976B2 (ja) * | 2010-09-14 | 2016-09-14 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチCouncil Of Scientific & Industrial Research | 病原体に対する持続性免疫および防御を生成させるのに有用な合成免疫原 |
US9433671B2 (en) | 2012-03-30 | 2016-09-06 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
US8883717B2 (en) | 2012-03-30 | 2014-11-11 | Artificial Cell Technologies, Inc. | Antigenic compositions and methods |
AU2015205567B2 (en) | 2014-01-09 | 2019-04-04 | Alpha-O Peptides Ag | Flagellin-containing protein nanoparticles as a vaccine platform |
US9968665B2 (en) | 2015-09-16 | 2018-05-15 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
-
2013
- 2013-03-14 US US13/828,315 patent/US8883717B2/en active Active
- 2013-03-20 BR BR112014024375-1A patent/BR112014024375B1/pt active IP Right Grant
- 2013-03-20 MX MX2014011712A patent/MX350707B/es active IP Right Grant
- 2013-03-20 AU AU2013240106A patent/AU2013240106B2/en active Active
- 2013-03-20 ES ES13713332.8T patent/ES2612357T3/es active Active
- 2013-03-20 JP JP2015503372A patent/JP6228967B2/ja active Active
- 2013-03-20 EP EP13713332.8A patent/EP2830652B1/en active Active
- 2013-03-20 DK DK13713332.8T patent/DK2830652T3/en active
- 2013-03-20 CN CN201610516099.XA patent/CN106110320A/zh active Pending
- 2013-03-20 CN CN201380017628.6A patent/CN104220089B/zh active Active
- 2013-03-20 WO PCT/US2013/033071 patent/WO2013148427A1/en active Application Filing
- 2013-03-20 CA CA2868455A patent/CA2868455C/en active Active
-
2014
- 2014-09-17 IL IL234695A patent/IL234695B/en active IP Right Grant
- 2014-10-08 US US14/509,477 patent/US9302001B2/en active Active
-
2015
- 2015-08-04 HK HK15107492.1A patent/HK1206970A1/xx unknown
-
2016
- 2016-02-24 US US15/052,013 patent/US9925252B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104220089A (zh) | 2014-12-17 |
EP2830652A1 (en) | 2015-02-04 |
ES2612357T3 (es) | 2017-05-16 |
MX350707B (es) | 2017-09-14 |
CA2868455A1 (en) | 2013-10-03 |
CA2868455C (en) | 2021-01-12 |
JP2015516954A (ja) | 2015-06-18 |
IL234695A0 (en) | 2014-11-30 |
JP6228967B2 (ja) | 2017-11-08 |
BR112014024375B1 (pt) | 2022-08-16 |
AU2013240106B2 (en) | 2016-11-10 |
WO2013148427A1 (en) | 2013-10-03 |
MX2014011712A (es) | 2015-02-04 |
EP2830652B1 (en) | 2016-11-02 |
US20160166669A1 (en) | 2016-06-16 |
DK2830652T3 (en) | 2017-01-30 |
CN106110320A (zh) | 2016-11-16 |
BR112014024375A2 (es) | 2017-06-20 |
US9925252B2 (en) | 2018-03-27 |
CN104220089B (zh) | 2016-08-24 |
AU2013240106A1 (en) | 2014-10-02 |
US9302001B2 (en) | 2016-04-05 |
US20130259946A1 (en) | 2013-10-03 |
IL234695B (en) | 2019-06-30 |
US20150030682A1 (en) | 2015-01-29 |
US8883717B2 (en) | 2014-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272539B (en) | Preparations and methods for immunotherapy | |
IL271305B (en) | Anti-ntb–a antibodies and related compositions and methods | |
EP2836212A4 (en) | NOVEL COMPOSITIONS AND METHOD | |
IL252566A0 (en) | Pharmacy preparations and methods | |
ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
EP2884984A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD | |
HK1206970A1 (en) | Antigenic compositions and methods | |
EP2854530A4 (en) | COMPOSITIONS AND METHODS FOR BETA-GLUCAN IMMUNOTHERAPY | |
GB201315350D0 (en) | Methods and compositions | |
GB201315347D0 (en) | Methods and compositions | |
ZA201308892B (en) | Compositions and methods | |
EP2852662A4 (en) | HERPESVIRUS COMPOSITIONS AND RELATED METHODS | |
EP2837624A4 (en) | 4-SUBSTITUTE-2-HYDROXYLMORPHOLIN-3-ON AND METHOD OF MANUFACTURING THEREOF | |
EP2766357A4 (en) | MESOBILIVERDINE COMPOSITIONS AND METHOD THEREFOR | |
EP2742139A4 (en) | IMMUNOGENIC COMPOSITIONS AND ASSOCIATED METHODS | |
GB201222820D0 (en) | Woolscouring method and composition | |
EP2879652A4 (en) | COMPOSITIONS AND METHODS FOR HAIR IMPROVEMENT | |
EP2834635A4 (en) | COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR | |
GB201206859D0 (en) | Method and composition | |
GB201208315D0 (en) | Pharmaceutical methods and compositions | |
ZA201500172B (en) | Plant-disease-control composition and plant-disease-control method | |
SI2830587T1 (sl) | Sestavek za zaščito in uravnoteženje kože | |
GB201222810D0 (en) | Woolscouring method and composition | |
GB201204512D0 (en) | Method and composition | |
GB201116340D0 (en) | Compositions and methods |